{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"17"},{"groupId":"OG004","value":"4"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"17"},{"groupId":"OG004","value":"4"}],"units":"Participants"}],"description":"Toxicity as defined by NCI Common Terminology Criteria for Adverse Events v 3.0","groups":[{"description":"Patients will receive intravenous clofarabine once daily for three consecutive days. Doses of clofarabine will start at 4 mg/m2/day and will be escalated to higher dose levels.","id":"OG000","title":"4 mg/m2/Day Clofarabine"},{"description":"Patients will receive intravenous clofarabine once daily for three consecutive days. Doses of clofarabine will start at 4 mg/m2/day and will be escalated to higher dose levels.","id":"OG001","title":"8 mg/m2/Day Clofarabine"},{"description":"Patients will receive intravenous clofarabine once daily for three consecutive days. Doses of clofarabine will start at 4 mg/m2/day and will be escalated to higher dose levels.","id":"OG002","title":"13.2 mg/m2/Day Clofarabine"},{"description":"Patients will receive intravenous clofarabine once daily for three consecutive days. Doses of clofarabine will start at 4 mg/m2/day and will be escalated to higher dose levels.","id":"OG003","title":"20 mg/m2/Day Clofarabine"},{"description":"Patients will receive intravenous clofarabine once daily for three consecutive days. Doses of clofarabine will start at 4 mg/m2/day and will be escalated to higher dose levels.","id":"OG004","title":"28 mg/m2/Day Clofarabine"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"2 years","title":"Participants Evaluated for Toxicity","type":"SECONDARY","unitOfMeasure":"Participants"}